Natixis Investment Managers International - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 54 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Natixis Investment Managers International ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q3 2018$425,000
+8.1%
4000.0%0.02%
-9.1%
Q2 2018$393,000
-1.3%
4000.0%0.02%
-21.4%
Q1 2018$398,000
-6.4%
4000.0%0.03%
-40.4%
Q4 2017$425,0004000.05%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q1 2018
NameSharesValueWeighting ↓
TENOR CAPITAL MANAGEMENT Co., L.P. 74,881,000$76,559,0001.97%
III Capital Management 15,000,000$15,227,0001.82%
TFG Asset Management GP Ltd 14,055,000$14,321,0001.02%
MACKAY SHIELDS LLC 28,304,000$28,739,0000.21%
RWC Asset Management LLP 6,500,000$6,604,0000.20%
PALISADE CAPITAL MANAGEMENT, LP 7,187,000$7,281,0000.17%
CQS (US), LLC 4,000,000$4,092,0000.13%
FARALLON CAPITAL MANAGEMENT LLC 24,435,000$24,797,0000.12%
D. E. Shaw & Co., Inc. 59,728,000$60,845,0000.06%
BNP Paribas Asset Management Holding S.A. 7,000,000$7,133,0000.03%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders